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ABSTRACT A novel technique is reported in which an antibody-sensitive electrode for anti-prostaglandin E2 antisera
was used to measure solution-phase PGE2 in nanomolar quantities. The electrode was constructed by incorporating a
cation-selective ionophore-hapten (PGE2) conjugate into a polyvinyl chloride membrane. Transmembrane potential in
a fixed potassium gradient was measured. The addition of anti-PGE2 antisera changed membrane potential in a
concentration-dependent manner. The effect of anti-PGE2 antibodies on membrane potential was decreased by adding
free PGE2 to the buffer-containing antisera. With this technique a competitive protein-binding assay was developed,
and standard curves for solution-phase PGE2 were generated over a concentration range of 1 to 1,000 nM. The assay
was relatively specific for PGE2; PGD2 and PGF2, had only minor effects on transmembrane potential over the effective
concentration range for PGE2-
INTRODUCTION
Radioimmunoassay (RIA) caused a revolution in the
technology available to endocrinologists and clinical chem-
ists, because it allowed relatively quick and inexpensive
analyses of biological chemicals that occur naturally in
small quantities. The few drawbacks of RIA are (a) the
radioisotopes used are expensive and require special han-
dling, and (b) the turn-around time for a measurement can
last several hours to several days if the expense of the assay
requires that many samples be accumulated before it
becomes economical to run an assay. Three years ago
Solsky and Rechnitz (1979) reported production of an
electrode capable of measuring antibody concentration.
This was achieved by incorporation of an ionophore-hapten
conjugate into a polyvinyl-chloride membrane. Antibodies
raised against the hapten used in the conjugate were
specifically sensed by the membrane causing an apparent
shift in the ion selectivity of the membrane (Solsky and
Rechnitz, 1981). Based on this previous work, it was likely
that other antibody-sensitive electrodes could be con-
structed for other antibody-hapten systems. We reasoned
that if the antibody-hapten interaction at the surface of
antibody-sensitive membranes were reversible, then it
would be possible to produce competition between the
membrane-conjugated hapten and hapten free in solution.
If the solution-phase hapten was present in high enough
concentration, most of the antibody molecules would be
unavailable to affect membrane potential. This should
produce potential changes across the membrane equivalent
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to reducing antibody concentration. These are the condi-
tions of a competitive protein binding assay where the
dependent variable is a potentiometric measurement. The
relative speed, simplicity, and freedom from use of isotopes
and hazardous chemicals make such a technique an attrac-
tive alternative to radioimmunoassays.
We have tested this hypothesis by constructing plastic
membranes containing covalent conjugates of dibenzo-
18-crown-6 (a cation-selective ionophore) and PGE2. The
membranes were installed in electrodes that responded
with potential changes to antibodies raised against PGE2-
protein conjugates. We have used these antibody-sensitive
electrodes in an electroimmunoassay, a competitive pro-
tein-binding assay that quantitates solution-phase PGE2
concentration by measuring transmembrane potential.
METHODS
Chemistry: Synthesis of lonophore-Hapten
Conjugate
Dibenzo- I 8-crown-6 was selected as the ionophore because its structure is
ideal for chemical modification. The benzene rings were used to attach
new functional groups to the ionophore to facilitate covalent coupling of
PGE2. An amide linkage utilizing the carboxylic group of PGE2 was
chosen for conjugation to the ionophore, because this was the site where
PGE2 was coupled to bovine thyroglobulin to produce antibodies directed
against PGE2 (Sanders, 1976). Dibenzo-18-crown-6 was nitrated; the
dinitro compound was reduced to a diamine; and an amide linkage to
PGE2 was produced by the mixed anhydride method (Bodanszky and
Ondetti, 1966).
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Synthesis of the trans-diamine of dibenzo- 1 8-crown-6 was carried out
in three steps: (a) nitration of dibenzo- 18-crown-6, (b) separation of the
cis and trans dinitro products, and (c) reduction to the trans-diamine. The
nitrated crown ether was produced by refluxing dibenzo- 18-crown-6
(PCR Research Chemicals Inc., PCR Inc., Gainsville, FL) with nitric
and acetic acid. Cis and trans dinitro products were separated by
crystallization. The trans-diamine was prepared by the catalytic reduc-
tion of the trans dinitro product. The crude diamino product was purified
by sublimation, and the synthesis was verified by melting point (MP)
(product, 198-203°C; literature, 199-2030C) and by infrared (IR)
(Feigenbaum and Michel, 1971).
PGE2 was reacted with triethyl amine and ethyl chloroformate to
produce a mixed anhydride of prostaglandin. Diamino-dibenzo-1 8-crown-
6 was added to the PGE2-mixed anhydride to covalently couple prosta-
glandin to the crown ether via amide linkages. This resulted in the
formation of the PGE2-trans-diamide of dibenzo-18-crown-6 (MP
1 340C). The product was purified by recrystallization in chloroform and
ethanol, and verified by IR, nuclear magnetic resonance (NMR), and fast
atom bombardment mass spectral analysis.
Production and Testing of
Antibody-sensitive Electrode
Polyvinyl chloride (PVC) membranes were prepared by dissolving iono-
phore or ionophore-PGE2 conjugate (1 mg/250 mg PVC) PVC, and
dibutyl sebacate in tetrahydrofuran. The solvent was removed by slow
evaporation, resulting in the formation of a flexible membrane, 0.2 mm
thick and 50mm in diameter. A disk of the plastic membrane (4mm x 0.2
mm) was installed into an electrode housing (92-00; Orion Research Inc.,
Cambridge, MA), which was positioned in a 4-ml jacketed Lucite test
chamber. Temperature in the internal compartment of the test chamber
was maintained at 250C by temperature regulated water flowing through
the outer compartment. The solution in the test chamber was stirred with
an air-driven magnetic stirring device and a small Teflon stir bar. The
solution could be exchanged via input and output ports in the test
chamber. Transmembrane potential was measured with an electrometer
(701; Orion Research Inc.) coupled to a junction reference electrode
(90-02; Orion Research Inc.). The internal chamber of the Orion 92-00
electrode was filled with 0.01 M KCI and was soaked in 0.1 M KCI for
several hours prior to testing. The external buffer solution (EBS)
consisted of 0.001 M KCI, 0.001 M Tris, and 0.051 M CaC12, such that
the ionic strength and pH were constant in all solutions at 0.154 M and
pH 7.2, respectively. Calcium and Tris ions had little or no effect on
membrane potential in the concentrations used. Data were recorded
either manually from the digital readout of the electrometer, or by a strip
chart recorder (2200; Gould Inc., Instruments Div., Santa Clara, CA).
RESULTS
Membrane Response to Anti-PGE2
Antiserum
Antibodies against PGE2 were raised in New Zealand
white rabbits by immunizing with covalent conjugates of
bovine thyroglobulin and PGE2 (Sanders, 1976). The sera
of preimmunized and immunized rabbits were collected,
lyophilized, and reconstituted in EBS. The effects of these
sera on membrane potential were tested on membranes
containing conjugates of dibenzo-18-crown-6 and PGE2.
The reconstituted sera were added to the test chamber in
20-.al aliquots. After each addition, the solution was stirred
and the steady state potential was recorded. After a total
addition of 100 ,ul, the membrane was washed by drawing
fresh buffer (50 ml) across the surface by suction. Then the
test chamber was emptied and refilled with fresh buffer.
The nonimmune serum had little effect on transmem-
brane potential, but sera from immunized animals pro-
duced a concentration-dependent shift in membrane poten-
tial (Fig. 1). The change in potential was similar to that
caused by increasing the K+ concentration of the external
buffer, suggesting that the anti-PGE2 antibodies either
affected the potassium gradient near the membrane sur-
face or decreased potassium selectivity. Antisera preab-
sorbed to saturation with PGE2 had negligible effects on
membrane potential. The antibody-membrane interaction
was also tested on membranes containing dibenzo-18-
crown-6 in a similar concentration as above, but without
PGE2 covalently coupled. These membranes were unre-
sponsive to either the immune or the nonimmune sera,
supporting the concept that the interaction between mem-
branes containing ionophore-hapten conjugates and anti-
bodies to the hapten is depended on the antibody-hapten
affinity.
The effect of the antibody on membrane potential was
reversible. The average time constant of the potential
response to antibody was 7.2 ± 0.3 min. When the
electrode was returned to buffer, the pre-antibody mem-
brane potential was restored with an average time constant
of 3.6 ± 0.2 min.
Effect of Solution-Phase PGE2 on the
Antibody Responses
The reversibility of the interaction between antibodies and
PGE2 conjugated to ionophore suggested that competition
between membrane and solution-phase PGE2 molecules
might be exploited in a competitive protein-binding assay
in which membrane potential is the dependent variable
(Fig. 2). To test this hypothesis anti-PGE2 serum was
diluted in EBS at a concentration from the linear portion of
the antibody-response curve (Fig. 1). Aliquots of the
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FIGURE 1 Response of antibody-sensitive PVC membranes to immune,
anti-POE2 (A£), and nonimmune (;,) sera. Membrane potential was
changed in a concentration-dependent manner by immune serum added
to the exteral solution. Concentration of antibody is expressed as total
protein (Lowrey et al., 1951).
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FIGURE 2 Schematic representation of electroimmunoassay. A shows a
hypothetical interaction between fixed PGE2 molecules conjugated to the
ionophore and anti-PGE2 antibodies. This interaction changes the trans-
membrane potential (Vm). The addition of free PGE2 to the system
results in competition between solution-phase and membrane-phase PGE2
for antibody binding sites (B). As the concentration of free PGE2 is
increased, a greater percentage of antibody molecules are displaced from
the membrane, resulting in a reduction in the voltage response caused by
the antibody.
diluted serum were added to a series of tubes. PGE2 was
added to each of the tubes to achieve concentrations
ranging from 3 to 860 nM. The electrode was first
immersed in an antiserum solution containing no PGE2,
and the maximal voltage response ( VO) was recorded. Then
the membrane was washed with buffer and the electrode
was immersed in one of the antiserum solutions containing
PGE2. This cycle was repeated until potential measure-
ments had been made on each of the PGE2-containing
antiserum samples. The VO response of the membrane was
reduced in a concentration-dependent manner by solution-
phase PGE2. These data provide a standard curve, such as
that shown in Fig. 3, which can be used for an electroim-
munoassay. The response time constants for samples con-
taining PGE2 were similar to the time constants of samples
without PGE2, so an entire standard curve could be
generated in <1 h.
Specificity of the PGE2 Assay
An important feature of a competitive protein-binding
assay is the series of tests in which other prostaglandins of
similar structure (PGD2 or PGFu) were substituted for
FIGURE 3 Standard curves for electroimmunoassay. A concentration of
antibody in the linear portion of the antibody-response curve (Fig. 1) was
selected. The voltage response at this antibody concentration (V.) was
decreased as a function of the solution-phase concentrations of PGE2 and
PGD2, but not by PGF2s.
PGE2 to generate standard curves as described above.
PGF2., a compound in which the keto function on the
cyclopentane ring of PGE2 is replaced with a hydroxyl
group, had negligible effects on the membrane response to
the antibody. PGD2, in which the keto and hydroxyl
functions of the cyclopentane ring are reversed, demon-
strated limited ability to reduce the effect of the antibody.
The specificity of the antibody in the electroimmunoassay
was similar to the specificity of the antibody in standard
radiometric assays (Sanders, 1976). Fig. 3 shows a com-
parison of standard curves in which PGD2 and PGF21 were
substituted for PGE2.
DISCUSSION
The major new concept introduced in this study is that
antibody-sensitive electrodes (Solsky and Rechnitz, 1979)
can be used in a competitive, protein-binding assay to
measure solution-phase hapten concentration. The speci-
ficity of this electroimmunoassay was similar to that
demonstrated by the antibody in standard radiometric
assays, but the sensitivity was lower (1-1,000 nM as
compared with 0.1-100 nM in a radiometric assay; San-
ders, 1976). It is conceivable that the performance could be
considerably enhanced by monoclonal antibodies (greater
specificity) or certain physical changes, such as membrane
geometry (surface area or thickness), conjugate concentra-
tion, or alterations in the covalent binding of the hapten to
the ionophore (insertion of spacer groups between the
ionophore and the hapten or increasing the hapten to
ionophore binding ratio).
There are several reasons to assume that the effect of
the anti-PGE2 antiserum on membrane potential was a
specific antibody-hapten interaction. Membrane potential
was affected by serum from immunized animals, but not
by serum from nonimmunized animals. This suggests that
the effect was not a nonspecific effect of protein on the
membrane. The effectiveness of the anti-PGE2 antiserum
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to alter membrane potential was abolished by preabsorbing
the antibody with PGE2, but not by similar concentrations
of PGFu. The similarities in the structures of PGE2 and
PGF2u suggest that there is highly specific recognition of
the membrane-bound PGE2 by the antibody. Membranes
containing ionophore that was not conjugated with PGE2
were not responsive to either immune or nonimmune sera.
The mechanism for the specific effect of antibody on
membrane potential is unknown. Solsky and Rechnitz
(1981) suggested that the antibody interaction may have
increased the selectivity of the membrane. Our results
suggest a different mechanism because the presence of
antibody caused a shift in transmembrane potential that is
more consistent with a decrease in selectivity or a decrease
in the potassium gradient. The latter might be due to the
acidic properties of serum proteins at pH 7.2 (Harper et
al., 1979), which might bind potassium and increase the
local concentration at the membrane surface. The mecha-
nism of the solution-phase hapten on the antibody-
membrane effect, while not directly studied in our experi-
ments, is consistent with the concept depicted in Fig. 2. It is
likely that the free PGE2 competes with the membrane-
bound PGE2 for antibody binding sites. At high concentra-
tions of solution-phase PGE2 most of the antibody binding
sites are occupied and unavailable to interact with the
membrane. This would have the same effect on membrane
potential as would lowering the antibody concentration.
A major drawback to electroimmunoassay as presented
here is the dependence on the ionic gradient, ionic strength,
and pH. In fact a criticism of our findings might be that we
changed the ionic concentration in our EBS by adding
reconstituted serum that was not dialyzed. We controlled
the addition of contaminant ions by performing tests in
which buffer solutions containing the ions at concentra-
tions found in sera were added in volumes equal to the
antibody additions. These tests showed that the low con-
centrations of contaminant ions introduced in our serum
dilutions either had no effect on membrane potential or a
slight change (<1 mV) in the opposite direction from the
effect of the antibody containing sera. Higher concentra-
tions or extended exposure to contaminant ions could
conceivably produce artifactual changes in membrane
potential. Therefore, assays of this type will probably
require preconditioning of the ionic composition of sam-
ples.
It is likely, based on our model study with prostaglan-
din, that electroimmunoassays for other immunogenic
compounds or haptens can be developed. The technique is a
potentially important advance in the study of endogenous,
biologically active substances and industrial monitoring of
the production of biochemicals if on line electroimmunoas-
say becomes feasible. In biological studies of local regula-
tory agents, such as prostaglandins, electroimmunoassay
probes may eventually provide vital information about
tissue, or even cellular concentrations of these agents.
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